2023 annual financial data
Caribou Biosciences 2023 Net margin
Direct answer
Net margin was -296.05%.
Operating income was -116.06M USD and net income was -102.07M USD.
Operating cash flow was -93.29M USD.
Get free Caribou Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 34.48M USD
- Operating income
- -116.06M USD
- Net income
- -102.07M USD
- Operating cash flow
- -93.29M USD